Sitemap
Medical science
00/0000 Factor XIII in man: A review
00/0000 Blood coagulation factor XIII: Activation, substrates and structure of a transglutaminase
00/0000 Factor XIII and endothelial barrier function
00/0000 Methods for the determination of factor XIII/XIIIa
00/0000 Inhibitors of factor XIIIa
00/0000 Clinical course and management of severe congenital factor XIII deficiency
00/0000 Role of coagulation factor XIII in cardio- and cerebrovascular diseases
00/0000 Factor XIII and wound healing
00/0000 The urokinase plasminogen activator and its receptor: Role in cell growth and apoptosis
00/0000 Thrombinography shows acquired resistance to activated protein C in patients with lupus anticoagulants
00/0000 Molecular mechanisms of leukocyte recruitment: organ-specific mechanisms of action
00/0000 A single complete ultrasound investigation of the venous network for the diagnostic management of patients with a clinically suspected first episode of deep venous thrombosis of the lower limbs
00/0000 Complete compression ultrasonography of the leg veins as a single test for the diagnosis of deep vein thrombosis
00/0000 Impaired prothrombinase activity of factor X Gly381Asp results in severe familial CRM+ FX deficiency
00/0000 Deficiency of tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) impairs nutritionally induced obesity in mice
00/0000 In vivo pig models of venous thrombosis mimicking human disease
00/0000 Different mechanisms contribute to the biphasic pattern of carboxypeptidase U (TAFIa) generation during in vitro clot lysis in human plasma
00/0000 Predisposing factors for enlargement of intracerebral hemorrhage in patients treated with warfarin
00/0000 Prospective assessment of the natural history of positive D-dimer results in persons with acute venous thromboembolism (DVT or PE)
00/0000 Direct thrombin inhibitor melagatran followed by oral ximelagatran in comparison with enoxaparin for prevention of venous thromboembolism after total hip or knee replacement
00/0000 A randomized trial of initial warfarin dosing based on simple clinical criteria
00/0000 Body mass index is associated with the development of the post-thrombotic syndrome
00/0000 Differential regulation of P-selectin expression by protein kinase A and protein kinase G in thrombin-stimulated human platelets
00/0000 A critical role of lipid rafts in the organization of a key FcRIIa-mediated signaling pathway in human platelets
00/0000 Activation-dependent surface expression of gC1qR/p33 on human blood platelets
00/0000 Activation of human platelets by 2-arachidonoylglycerol is enhanced by serotonin
00/0000 Effect of fibrinogen concentration and platelet count on the inhibitory effect of abciximab and tirofiban
00/0000 Blood coagulation and fibrinolytic factors in 105 patients with hemorrhagic syndrome caused by accidental contact with Lonomia obliqua caterpillar in Santa Catarina, Southern Brazil
00/0000 Effect of clotting factors concentrates on lymphocyte and neutrophil function in vitro
00/0000 Fibrinolytic capacity increases with age in healthy humans, while endothelium-dependent vasodilation is unaffected
00/0000 Human/chicken urokinase chimeras demonstrate sequences outside the serine protease domain that dictate autoactivation
00/0000 Aging of stromal-derived human breast fibroblasts might contribute to breast cancer progression
00/0000 Coagulopathy of sepsis
00/0000 Systematic review of studies of self-management of oral anticoagulation
00/0000 Thrombin binding to GPIb induces integrin IIb3 dependent platelet adhesion to fibrin in ex vivo flowing whole blood
00/0000 Activated protein C generation is greatly decreased in plasma from newborns compared to adults in the presence or absence of endothelium
00/0000 The TF-603A/G gene promoter polymorphism and circulating monocyte tissue factor gene expression in healthy volunteers
00/0000 Anti-prothrombin antibodies as a potential risk factor of recurrent venous thromboembolism
00/0000 Extracorporeal adsorption of anti-Factor VIII allo-antibodies on randomly functionalized polystyrene resins
00/0000 Factor VIII expression in liver disease
00/0000 Titre of anti-heparin/PF4-antibodies and extent of in vivo activation of the coagulation and fibrinolytic systems
00/0000 Efficacy of AT in pre-eclampsia: a case-control prospective trial
00/0000 Maternal thrombophilias are not associated with early pregnancy loss
00/0000 Effect of age on the performance of single detector helical computed tomography in suspected pulmonary embolism
00/0000 Local INR calibration of the Owren type prothrombin assay greatly improves the intra- and interlaboratory variation
00/0000 Increased fasting total homocysteine plasma levels as a risk factor for thromboembolism in children
00/0000 Effects of a snake venom metalloproteinase, triflamp, on platelet aggregation, platelet-neutrophil and neutrophil-neutrophil interactions: involvement of platelet GPIb and neutrophil PSGL-1
00/0000 Plasma membrane Ca2+ -ATPase (PMCA) translocates to filopodia during platelet activation
00/0000 Platelets in patients with acute ischemic stroke are exhausted and refractory to thrombin, due to cleavage of the seven-transmembrane thrombin receptor (PAR-1)
00/0000 Sustained elevated amounts of circulating procoagulant membrane microparticles and soluble GPV after acute myocardial infarction in diabetes mellitus
00/0000 Influence of plasma and erythrocyte factors on red blood cell aggregation in survivors of acute myocardial infarction
00/0000 Relationships between plasma adiponectin and blood cells, hepatopancreatic enzymes in women
00/0000 Effects of biological variations on platelet count in healthy subjects in China
00/0000 Beneficial effects of vitamins D and K on the elastic properties of the vessel wall in postmenopausal women: a follow-up study
00/0000 Myocardial damage, coagulation activity and the response to thrombin inhibition in unstable coronary artery disease
00/0000 Long term prognosis of patients with myocardial infarction and normal coronary angiography: impact of inherited coagulation disorders
00/0000 Low-dose warfarin in atrial fibrillation leads to more thromboembolic events without reducing major bleeding when compared to adjusted-dose A meta-analysis
00/0000 Metabolism of tumour-derived urokinase receptor and receptor fragments in cancer patients and xenografted mice
00/0000 Oral contraceptives, hormone replacement therapy, thrombophilias and risk of venous thromboembolism: a systematic review. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study
00/0000 Polymorphisms of haemostasis genes as risk factors for preterm delivery
00/0000 Glycoprotein IIb/IIIa inhibition reduces prothrombotic events under conditions of deep hypothermic circulatory arrest
00/0000 Soluble and cleaved forms of the urokinase-receptor: degradation products or active molecules?
00/0000 Roles of the multifunctional glycoprotein, emmprin (basigin; CD147), in tumour progression
00/0000 Myocardial extra-cellular matrix and its regulation by metalloproteinases and their inhibitors
00/0000 Poly(ADP-ribosyl)ation, a molecular switch of transcription, shows an attractive relationship with urokinase expression
00/0000 Circulating endothelial cells. Biomarker of vascular disease
00/0000 Asymptomatic postoperativedeep vein thrombosisand the development of postthrombotic syndrome. Asystematic reviewand meta-analysis
00/0000 Towards optimization of selective photothermolysis: prothrombotic pharmaceutical agents as potential adjuvants in laser treatment of port wine stains. A theoretical study
00/0000 The adaptive immune system and long-term outcome in patients with stable coronary disease. Predictive value of routine laboratory measurements
00/0000 A reunification of the US (NIH) and International Unit into a single standard for Thrombin
Back
Search
